Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-11-14 1:22 pm Purchase |
2024-09-30 | 13G | IGM Biosciences, Inc. IGMS |
T. Rowe Price Associates, Inc. | 4,014,259 11.800% |
610,545![]() (+17.94%) |
Filing History |
2024-11-14 1:22 pm Purchase |
2024-09-30 | 13G | Bill.com Holdings, Inc. BILL |
T. Rowe Price Associates, Inc. | 11,672,415 10.900% |
605,611![]() (+5.47%) |
Filing History |
2024-11-14 1:22 pm Sale |
2024-09-30 | 13G | Sphere Entertainment Co. SPHR |
T. Rowe Price Associates, Inc. | 48,847 0.200% |
-1,669,011![]() (-97.16%) |
Filing History |
2024-11-14 1:22 pm Sale |
2024-09-30 | 13G | C4 Therapeutics, Inc. CCCC |
T. Rowe Price Associates, Inc. | 392,004 0.600% |
-2,166,476![]() (-84.68%) |
Filing History |
2024-11-14 1:22 pm Purchase |
2024-09-30 | 13G | Pliant Therapeutics, Inc. PLRX |
T. Rowe Price Associates, Inc. | 4,834,813 8.000% |
1,046,697![]() (+27.63%) |
Filing History |
2024-11-14 1:22 pm Purchase |
2024-09-30 | 13G | Legend Biotech Corporation LEGN |
T. Rowe Price Associates, Inc. | 11,165,584 6.100% |
357,368![]() (+3.31%) |
Filing History |
2024-11-14 1:22 pm Sale |
2024-09-30 | 13G | Xometry, Inc. XMTR |
T. Rowe Price Associates, Inc. | 115,251 0.200% |
-2,596,417![]() (-95.75%) |
Filing History |
2024-11-14 1:22 pm Purchase |
2024-09-30 | 13G | Kymera Therapeutics, Inc. KYMR |
T. Rowe Price Associates, Inc. | 6,645,474 10.300% |
646,218![]() (+10.77%) |
Filing History |
2024-11-14 1:22 pm Purchase |
2024-09-30 | 13G | StepStone Group Inc. STEP |
T. Rowe Price Associates, Inc. | 4,704,354 6.900% |
4,428,847![]() (+1607.53%) |
Filing History |
2024-11-14 1:22 pm Sale |
2024-09-30 | 13G | Tenaya Therapeutics, Inc. TNYA |
T. Rowe Price Associates, Inc. | 3,028,435 3.800% |
-1,516,108![]() (-33.36%) |
Filing History |
2024-11-14 1:22 pm Purchase |
2024-09-30 | 13G | Praxis Precision Medicines, Inc. PRAX |
T. Rowe Price Associates, Inc. | 1,120,080 6.300% |
1,120,080![]() (New Position) |
Filing History |
2024-11-14 1:22 pm Purchase |
2024-09-30 | 13G | Monte Rosa Therapeutics, Inc. GLUE |
T. Rowe Price Associates, Inc. | 6,601,141 10.800% |
1,504,354![]() (+29.52%) |
Filing History |
2024-11-14 1:22 pm Sale |
2024-09-30 | 13G | Immunocore Holdings plc IMCR |
T. Rowe Price Associates, Inc. | 2,347,759 4.700% |
-596,815![]() (-20.27%) |
Filing History |
2024-11-14 1:22 pm Sale |
2024-09-30 | 13G | Procore Technologies, Inc. PCOR |
T. Rowe Price Associates, Inc. | 5,117,330 3.500% |
-3,947,574![]() (-43.55%) |
Filing History |
2024-11-14 1:22 pm Sale |
2024-09-30 | 13G | monday.com Ltd. MNDY |
T. Rowe Price Associates, Inc. | 1,784,393 3.600% |
-1,348,869![]() (-43.05%) |
Filing History |
2024-11-14 1:22 pm Sale |
2024-09-30 | 13G | Aurora Innovation, Inc. AUR |
T. Rowe Price Associates, Inc. | 23,504,302 1.800% |
-36,320,080![]() (-60.71%) |
Filing History |
2024-11-14 1:22 pm Purchase |
2024-09-30 | 13G | Vera Therapeutics, Inc. VERA |
T. Rowe Price Associates, Inc. | 3,939,109 7.200% |
3,939,109![]() (New Position) |
Filing History |
2024-11-14 1:22 pm Sale |
2024-09-30 | 13G | Confluent, Inc. CFLT |
T. Rowe Price Associates, Inc. | 5,829,015 2.300% |
-9,165,730![]() (-61.13%) |
Filing History |
2024-11-14 1:22 pm Purchase |
2024-09-30 | 13G | Samsara Inc. IOT |
T. Rowe Price Associates, Inc. | 16,434,067 7.300% |
1,592,252![]() (+10.73%) |
Filing History |
2024-11-14 1:22 pm Purchase |
2024-09-30 | 13G | CARGO Therapeutics, Inc. Common Stock CRGX |
T. Rowe Price Associates, Inc. | 2,694,306 5.900% |
455,799![]() (+20.36%) |
Filing History |